WallStreetZen

NYSE: BMY
Bristol Myers Squibb Co Stock Ownership

Insider buying vs selling

Have Bristol Myers Squibb Co insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Giovanni CaforioBoard Chair and CEO2021-09-2025,000$60.64
$1.52MSell
David V. ElkinsEVP Chief Financial Officer2021-08-126,180$48.49
$299.67kBuy
David V. ElkinsEVP Chief Financial Officer2021-08-1259,691$48.49
$2.89MBuy
David V. ElkinsEVP Chief Financial Officer2021-08-124,129$48.49
$200.22kBuy
David V. ElkinsEVP Chief Financial Officer2021-08-1259,691$67.00
$4.00MSell
David V. ElkinsEVP Chief Financial Officer2021-08-1240,000$66.88
$2.68MSell
Ann PowellEVP Chief Human Resources2021-08-0323,280$68.57
$1.60MSell
Giovanni CaforioChairman and CEO2021-08-0220,000$68.58
$1.37MSell
David V. ElkinsEVP Chief Financial Officer2021-08-0123,736$67.87
$1.61MSell
Rupert VesseyEVP Research & Early Dev.2021-07-3017,630$56.44
$995.04kBuy

1 of 11

BMY insiders have sold more BMY shares than they have bought in the last year
Ownership

BMY Shareholders

What type of owners hold Bristol Myers Squibb Co stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc8.88%197,341,430$11.52BInstitution
Blackrock Inc7.88%175,100,707$10.22BInstitution
State Street Corp4.15%92,145,348$5.38BInstitution
Jpmorgan Chase Co3.75%83,298,152$4.86BInstitution
Fmr LLC3.08%68,475,862$4.00BInstitution
Wellington Management Group Llp1.98%43,963,060$2.57BInstitution
Geode Capital Management LLC1.62%35,957,818$2.10BInstitution
Ameriprise Financial Inc1.36%30,215,938$1.76BInstitution
Bank Of America Corp1.29%28,607,490$1.67BInstitution
Dodge Cox1.28%28,473,658$1.66BInstitution

1 of 3

Bristol Myers Squibb Stock Ownership FAQ

Who owns Bristol Myers Squibb?

Bristol Myers Squibb (NYSE: BMY) is owned by 72.03% institutional shareholders, 0.31% Bristol Myers Squibb insiders, and 27.66% retail investors. Vanguard Group Inc is the largest individual Bristol Myers Squibb shareholder, owning 197.34M shares representing 8.88% of the company. Vanguard Group Inc's Bristol Myers Squibb shares are currently valued at $11.24B.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.